AlphaYouJM
Insider selling
James M Mock sold $4.7M of Moderna, Inc. (MRNA) stock
James M Mock, Chief Financial Officer of Moderna, Inc. (MRNA), sold 34,836 shares of MRNA stock worth $4.7M, per an SEC Form 4 filed Sep 14, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 10, 2026, 4 days before it was made public.
MRNA has moved +26.6% since the trade date, from $136.62 to $172.94 (Sep 21, 2026 close).
- Traded
- Sep 10, 2026
- Disclosed
- Sep 14, 2026
- Filing delay
- 4 days
- Price since
- +26.6%
- Role
- Chief Financial Officer
- Source
- SEC Form 4
More MRNA insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.